Biofield diagnostic system

Biofield diagnostic system

A diagnostic system that uses sensors (similar to EKG) that fire electropotential signals through tissue to distinguish between benign and malignant lesions.

The system is not FDA approved for commercial marketing or use.
References in periodicals archive ?
the developer of an investigational breast bioelectric potential measurement method known as the Biofield Diagnostic System (BDS).
The Biofield Diagnostic System was evaluated in a study of 661 women at eight leading European medical centres who had undergone a biopsy for suspicious breast lesions.
OTCBB:BZEC), today announced that it has shipped the initial order of its proprietary Biofield Diagnostic System for the early detection of breast cancer units (the "BDS"), to an exclusive distributor representing the Mexican, Central and Latin American markets.
FDA approval to distribute the Company's proprietary Biofield Diagnostic System for the early detection of breast cancer (the "BDS") in the U.
is a developmental stage medical technology company that has developed the Biofield Diagnostic System (BDS), a device for detecting breast cancer in a non-invasive procedure.
is a development-stage medical technology company that has developed a device to assist in detecting breast cancer in a non-invasive procedure, the Biofield Diagnostic System (BDS).
The new China HQ will oversee and manage the Carelife JVs, which will distribute, test, further develop, and gather critical medical data from the Biofield Diagnostic System (BDS) and other medical technology in conjunction with leading Chinese governmental healthcare organizations, hospitals, testing centers, doctors, medical organizations, insurance companies, and banks.
The Company's breast cancer diagnostic device, the Biofield Diagnostic System (BDS), employs single-use sensors designed by Biofield and a measurement device to detect and analyze changes associated with the development of epithelial cancers, such as breast cancer.